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Abstract
Background: DING proteins encompass an intriguing protein family first characterized by their conserved N-terminal
sequences. Some of these proteins seem to have key roles in various human diseases, e.g., rheumatoid arthritis,
atherosclerosis, HIV suppression. Although this protein family seems to be ubiquitous in eukaryotes, their genes are
consistently lacking from genomic databases. Such a lack has considerably hampered functional studies and has fostered
therefore the hypothesis that DING proteins isolated from eukaryotes were in fact prokaryotic contaminants.
Principal Findings: In the framework of our study, we have performed a comprehensive immunological detection of DING
proteins in mice. We demonstrate that DING proteins are present in all tissues tested as isoforms of various molecular
weights (MWs). Their intracellular localization is tissue-dependant, being exclusively nuclear in neurons, but cytoplasmic and
nuclear in other tissues. We also provide evidence that germ-free mouse plasma contains as much DING protein as wild-
type.
Significance: Hence, data herein provide a valuable basis for future investigations aimed at eukaryotic DING proteins,
revealing that these proteins seem ubiquitous in mouse tissue. Our results strongly suggest that mouse DING proteins are
endogenous. Moreover, the determination in this study of the precise cellular localization of DING proteins constitute a
precious evidence to understand their molecular involvements in their related human diseases.
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Introduction
DING proteins, named according to their four conserved N-
terminal amino-acid residues, encompass a recently discovered
protein family [1]. Intriguingly, eukaryotic DING genes are
consistently missing from genomic databases although proteins
belonging to this family seem to be ubiquitous in eukaryotes: they
have been identified in animals (human, monkey, rat, turkey),
plants (Hypericum perforatum, Arabidopsis thaliana, potato, tobacco)
and fungi (Candida albicans, Ganoderma lucidum) [2,3] mostly as a
40 kDa protein or higher molecular weight DING proteins [4].
Although no complete eukaryotic DING coding sequence is
available in databases, few partial DNA sequences have been
either cloned [3] or identified in non-annoted parts of genomes
[2]. These few pieces of sequences show that DING proteins are
strongly conserved [2]. DING proteins have also been isolated
from several prokaryotes [5,6], and their coding genes are in some
cases available, such as the gene encoding PfluDING, the protein
isolated from P. fluorescens [7,8,9]. The high sequence identity
between known eukaryotic DING sequences and available
prokaryotic DING sequences (.70% sequence identity) and the
systematic absence of eukaryotic DING genes raised a controversy
about their prokaryotic [10] or eukaryotic origins [11].
DING proteins have been mostly isolated by virtue of a
biological function. One of the most striking examples as such,
remains the search for a new HIV inhibitor in St John’s Wort that
led to the characterization of a novel DING protein named p27
sj
[3]. In humans, several DING proteins have been identified from
different tissues [2,12,13]. The human phosphate binding protein
(HPBP) is a serendipitously discovered plasma apolipoprotein that
binds phosphate and is isolated from human plasma [14,15].
HPBP structure was solved [16] and its physiological function, i.e.
its association with paraoxonase (HPON1), an enzyme involved in
atherosclerosis [17], has been extensively studied [18,19,20]. The
complete protein sequence of HPBP was recently determined by a
tandem use of mass spectrometry and X-ray crystallography [21].
Such a sequence stands out as the single complete eukaryotic
sequence of a DING representative, known to date. Three other
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(CAI), the human synovial stimulatory protein (SSP), and the X-
DING-CD4
+ from human CD4
+ T lymphocytes [22]. Compar-
ison of sequenced N-terminal and internal HPBP, CAI SSP, and
X-DING-CD4
+ peptides strongly suggests these stem from 4
different genes, all lacking from the sequenced human genome.
The CAI isolated from human kidney cells is assumed to prevent
the growth of kidney stones [23]. The SSP, isolated from human
synovial liquid, possesses auto-antigen activity, lymphocyte
stimulatory activity and a putative role in the etiology of
rheumatoid arthritis [24,25]. The X-DING-CD4
+ was isolated
from CD4+ T cells that are resistant to HIV infection and was
shown to block the HIV-1 LTR promoted expression and the
replication of HIV-1 [22]. The involvement of DING proteins in a
large spectrum of diseases enhances the potential therapeutic value
of this specific protein family, and further raises the question of the
molecular mechanisms involved in such biological properties.
Although the amount of data concerning this protein family has
increased over the last few years, their physiological functions
remain largely unknown, and their origin in eukaryotes is still
under debate. Hence, we performed a mapping of the DING
localization in a murine model.
This study focused on several mouse tissues i.e. brain, liver,
lung, heart, aorta, artery and skin. Findings revealed that
eukaryotic DING proteins have an intracellular localization. It
also provides an essential background for future investigations as
regards the numerous biological roles of eukaryotic DING
proteins.
Material and Methods
Animal Care and Sample Collection
Nine-week old adult male B6D2F1/j@rj mice (Janvier Labo-
ratories - France) were housed in cages under standard conditions
of temperature (24uC) and humidity (50–60%), with lights on
between 07:00 and 19:00. Mice had free access to water and
standard laboratory chow.
All the experiments in our study were reviewed and approved
by the Institutional Animal Care and Research Advisory
Committee in accordance with French law and leading interna-
tional guidelines.
Pentobarbital (80 mg/kg) anaesthetized mice were sacrificed by
intracardiac perfusion of saline with heparin (5 UI/ml) followed
by a fixative solution of 4% formaldehyde and 3% acetic acid in
saline. Brain, liver, lung, heart, aorta artery and skin were
collected, post-fixed in 4% formaldehyde for 48 hours and then
processed for paraffin embedding. For the brain tissue, coronal
sections (6 mm thick) were serially cut with a microtome at
+0.74 mm (ventricular and striatal areas) and –1.82 mm (hippo-
campus area) from the bregma, as shown in the Franklin and
Paxinos stereotaxic mouse brain atlas [26]. For all other collected
tissues (liver, lung, heart, aorta artery and skin), transverse sections
were prepared.
Plasma was purified from wild-type and germ-free C57BL/6
mouse blood using standard protocols. Wild-type and germ-free
C57BL/6 mouse plasma was kindly provided by the European
Mouse Mutant Archive (EMMA; http://emmanet.org).
Histological Staining
Hemalun-phloxin (H&P) staining was performed on paraffin-
embedded tissue sections as previously described by Lillie and
Fullmer [27]. For skin and lung sections, a saffron staining step
was added after the H&P staining (incubation of sections in 2%
saffron solution in ethanol for 10 min).
Immunohistochemistry
HPBP was purified from human blood plasma as previously
described [28]. Rabbit polyclonal and mouse monoclonal
antibodies raised against HPBP were prepared by the Genecust
Company (Dudelange, Luxembourg) using standard protocols. All
polyclonal antibodies and some monoclonal antibodies raised
against HPBP are able to recognize other eukaryotic DING
proteins, because of the high sequence identity existing in this
family.
For DING protein immunohistochemistry, sections from all
tested tissues were deparaffinized, rehydrated and treated for
10 min in TBS containing 0.3% v/v H2O2. For brain tissue, a
demasking step in boiling 1 mM EDTA pH 8.0 for 20 min was
added. Sections were then successively incubated for 1 h at room
temperature in TBS-BSA (TBS containing 1% w/v BSA) and
overnight at +4uC in TBS-BSA containing primary antibodies.
After 3 washes (15 min each) in TBS, secondary biotinylated IgG
antibodies in TBS-BSA were applied to sections for 1 h at room
temperature. Visualisation was performed using Vectastain ABC
Elite kit (Vector) and diaminobenzidine (DAB; Sigma). Dilutions
for primary and secondary antibodies were: as follows 1:1000
rabbit polyclonal anti-HPBP (antibody C); 1:50 mouse monoclonal
anti-HPBP (antibody 1D3 targeting the N-terminal peptide of
HPBP); 1:400 biotinylated anti-rabbit IgG (Vector) and 1:1000
biotinylated anti-mouse IgG (Vector). To ensure proper control
processing, some sections from all tested tissues were similarly
treated except for the fact that the incubation step in monoclonal
or polyclonal HPBP primary antibodies was omitted. In addition,
to assess the specificity of polyclonal HPBP antibody, a
competition experiment was conducted by adding 0.4, 2, 10 or
40 mg of purified HPBP on brain section slides (3 brain sections
per slide) in the primary antibody incubation step.
The following markers were considered for visualization of the
main types of specific brain cells: GFAP for activated astroglia,
Griffonia simplifolia lectin (GSA) for activated microglia and NeuN for
mature neurons. Double-labeling detections were achieved on
deparaffinized and hydrated sections by performing DAB-stained
DING protein immunochemistry (brown staining) as described
above,followedbyGFAPorNeuNimmunolabelingusingSGvector
dye (blue staining) for visualization [29]. For the detection of DING
protein in activated microglia, GSA staining was carried out as
previously described by Streit [30] with DAB-staining, followed by
DING protein immunochemistry using SG vector as dye revelator.
In control mice, GFAP or GSA staining is very faint since
activated astroglial and microglial cells are almost completely
absent. Therefore, for the specific detection of DING protein in
activated glial cells, brain sections from soman-intoxicated mice
were used. Soman, an irreversible cholinesterase inhibitor, is a
powerful warfare neurotoxicant triggering epileptic seizures
leading to neuronal cell death and subsequent glial activation
[29]. For this purpose, nine week old adult male B6D2F1/j@rj
mice were subcutaneously injected with 110 mg/kg soman (200 ml
in saline buffer; soman was provided by the ‘‘Centre d’Etudes du
Bouchet’’ - France) followed 1 min. later by an intraperitoneal
injection (200 ml in saline) of 5.0 mg/kg atropine methyl nitrate.
Pentobarbital (80 mg/kg) anaesthetized mice were sacrificed on
day 3 (pick of microglial cell activation) and day 8 (pick of
astroglial cell activation) post-poisoning using intracardiac perfu-
sion of formaldehyde and collected brains were processed for
immunohistochemistry as described above for control mice.
Western Blots Assays
Anaesthetized mice were decapitated and tissues such as the
whole brain without cerebellum, liver, lung, shaven skin and heart
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homogenized with a mini-potter in 5 volumes of cold RIPA buffer
containing 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM
EDTA, 1% v/v NP40, 0.5% w/v SDS, 0.5% w/v deoxycholic
acid and 0.5% v/v protease inhibitor cocktail set III (Calbiochem -
Merck). Lung, skin or heart were disrupted using a mixer mill
(Retsch MM301) calibrated for two sessions of 2 min shaking
each, at 30 Hz. For disruption, tissues were transferred in a 2 ml
microfuge tube containing 5 volumes of cold RIPA buffer (see
above) and two 3 mm tungsten carbide beads (Retsch). Subse-
quently, homogenates were centrifuged at 14000 g for 20 min at
+4uC and supernatants were frozen at 220uC for further western
blot analysis. Prior to freezing, protein concentrations were
determined in the supernatants, using the Lowry method [31].
Western immunoblotting was achieved as previously described
[32]. For each tissue homogenate or plasma sample, 20 mg of total
protein per well were loaded onto a 10% SDS-PAGE gel. Gel
electro-transfer was performed onto 0.2 mm nitrocellulose mem-
brane using a specific transfer buffer (48 mM Tris; 39 mM
glycine; 20% methanol; 1.3 mM SDS; pH 9.2). For DING
proteins detection on tissues, membranes were incubated with
1:400 monoclonal HPBP antibody and 1:1000 biotinylated-IgG
anti-mouse (Vector). Western blots on plasma samples were
performed using 1:2000 polyclonal anti-DING antibodies and
1:2500 anti-rabbit antibodies (BioRad). The size of DING proteins
bands was calculated according to the migration of Precision plus
protein kaleidoscope standard (BioRad) on the same gel for all
experiments, except for the western blot on plasma samples, where
Prestained Protein Ladder was used (Fermentas life science).
Results
Western Blot Analysis
Western blot analysis was performed on brain, shaven skin,
lung, heart and liver prepared from B6D2F1 mouse samples. Anti-
DING monoclonal antibody revealed several bands ranging from
41 to 140 kDa in all tested mouse tissues (Figure 1). The 41 kDa
protein band corresponds to the size of eukaryotic DING proteins
already described in the literature [1]. Intensities of 41 kDa bands
were very similar in all tested mouse tissues except in shaven skin
where the band intensity is weaker. Other bands between 52 and
140 kDa are more likely high molecular weight DING proteins
(HMW-DING) comparable to the ones already observed in plants
[4]. A similar band pattern was found in mouse lung, heart and
liver with 4 major HMW-DING bands located at 140 kDa,
71 kDa (double band of HMW-DING), 62 kDa and 52 kDa. In
the heart, the intensity of the double 71 kDa band is more
important than the one detected in lung and liver. In the brain, the
3 HMW-DING bands at 140 kDa, 71 kDa (double band) and
62 kDa are revealed but the 52 kDa HMW-DING protein was
not present. In the shaven skin, only one HMW-DING was
identified with a very intense band located at 52 kDa (Figure 1).
Furthermore, western blot analysis was carried out on plasma
purified from wild-type or germ-free C57BL/6 mice to determine
whether or not the presence of DING proteins in rodent was due
to a symbiotic or contaminating microbe. In both wild-type and
germ-free C57BL/6 plasma, a similar pattern was observed
(Figure 2). This indicates that plasma DING proteins do not
originate from bacteria but are directly produced by eukaryotic
cells and are subsequently secreted in the circulating blood. Anti-
DING polyclonal antibody revealed several bands ranging from 35
to 130 kDa, with a slightly different pattern from that observed in
mouse tissues. As a case in point, 2 bands of HMW-DING at
130 kDa and 100 kDa and a shorter DING protein of 35 kDa
were specifically observed. On the other hand, 2 bands
corresponding to HMW-DING at 52 kDa and 71 kDa were
shared with other mouse tissues. The band at 71 kDa is very
strong, suggesting that this isoform is widely predominant in
mouse plasma.
DING Protein Detection in the Mouse Brain
DING protein staining was detected in all cerebral regions of
brain sections using polyclonal antibody. The specificity of the
polyclonal antibody was verified in competition experiments
where various quantities of purified HPBP (ranging from 0.4 to
10 mg per brain section) were added in the primary antibody
incubation step (Figure 3). The addition of 0.4 mg HPBP
(Figure 3B) is sufficient enough to induce a significant reduction
of the intensity of DING immunolabeling previously observed in
brain sections in absence of purified HPBP competitor
(Figure 3A). An almost complete depletion of DING protein
immunolabeling was obtained by the addition of either 2 or 10 mg
Figure 1. Characterization of DING proteins by western blot
analysis. Western blots were achieved with protein homogenates
prepared from B6D2F1 mouse brain, shaven skin, lung, heart and liver
(loading of 20 mg total proteins in each well). DING proteins were
identified with mouse monoclonal anti-DING antibody. Diaminobenzi-
dine was used for the band revelation. Abbreviations are: B = brain; S
= shaven skin; Lu = lung; H = heart; Li = liver; HMW = high molecular
weight.
doi:10.1371/journal.pone.0009099.g001
Figure 2. Western blot analysis on plasma samples from
normal and germ-free mouse. Western blot was achieved with
plasma from wild type and germ-free C57BL/6 mice (loading of 20 mg
total proteins in each well). Abbreviations are: normal = wild-type and
GF = germ-free.
doi:10.1371/journal.pone.0009099.g002
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demonstrates the high specificity of polyclonal antibody raised
against mouse DING proteins and HPBP.
In the brain, DING labeling was exclusively detected in cell
nuclei but following two different staining patterns. In the first
one, the whole nucleus is strongly labeled (Figure 4A). This
labeling can be either evenly distributed throughout the nucleus
or some more intensely stained patches can be spotted in the
labeled nuclei. In the second pattern, detected DING proteins
appeared as small patches scattered in a poorly labeled nucleus
(Figure 4A). The relative proportion of strongly- or poorly-
labeled nuclei is dependent on thec o n s i d e r e dc e r e b r a lr e g i o n s .
For example, strongly-labeled nuclei are almost entirely present
in epithelial cells constituting blood vessels (Figure 4F)a n da r e
dominant in cells located in the subventricular zone and the
cerebral cortex (Figures 4B and 4C). In contrast, the majority
of ‘‘poorly’’-labeled nuclei are found in the lateral septum, the
striatum and the hippocampus (dentate gyrus and CA1, CA2 or
CA3 hippocampal fields). Regardless of the strongly- or poorly-
stained status of nuclei, the distribution of DING protein-
positive cells is also dependent on the related brain areas. In a
semi-qualitative study, the highest number of labeled cells was
observed in the granular layer of the dentate gyrus (Figure 4E),
the CA1, CA2 and CA3 fields of the hippocampus and the
subventricular zone (Figure 4B). To a lesser extent, the density
of DING protein-labeled cells is also important in the
hypothalamus, the corpus callosum, the amygdala, the choroid
plexus and all cortices including cingular, piriform and cerebral
cortices (Figure 4C). The quantity of DING protein-positive
cells was low in the thalamus (Figure 4D), the lateral septum,
the striatum and some hippocampal areas deprived of
pyramidal neurons such as the stratum radiatum, the lacuno-
sum moleculare layer and the molecular layer of the dentate
gyrus.
Both H&P staining and DING protein immunochemistry were
combined on same brain sections (co-labeling experiments) to
ensure that all brain nuclei are positively labeled with anti-DING
antibody (data not shown). In all checked cerebral regions, non-
H&P-stained nuclei were deprived of DING protein labeling.
Therefore, the density of DING protein labeling in a given brain
area is directly correlated to the density of cell nuclei in the specific
cerebral region.
The presence of large numbers of DING protein-positive cells in
the hippocampal CA1 field or in the granular layer of the dentate
gyrus undoubtedly means that these positively-stained cells are
neurons since these brain areas involve pyramidal neurons for the
most part. As assessed by DING protein/NeuN double labeling
(Figures 5A and 5B), co-localization of NeuN and DING
proteins was observed in many cell nuclei confirming the presence
of DING protein in neurons throughout the brain.
To address the issue as to whether DING protein was also
present in astroglial or microglial cells, DING protein/GFAP or
DING protein/lectin GSA double staining were performed in the
brain of soman-poisoned mice, respectively. Usually, resting glial
cells are not easy to detect due to the thinness of their perinuclear
cytoplasmic processes and the smallness of their nuclei. Therefore,
a mouse model containing activated glial cells with prominent
cytoplasmic branching processes and hypertrophied nuclei,
namely the soman-intoxicated mouse, was chosen. The presence
of DING protein was demonstrated in numerous activated
microglial or astroglial cells after soman poisoning, as shown in
Figures 5C and 5D, respectively.
Figure 3. Competition assays to assess polyclonal antibody
specificity. Anti-DING immunohistochemistry was performed on brain
sections from control mice (panel A). In a competition experiment,
0.4 mg (panel B), 2 mg (panel C) or 10 mg (panel D) of human purified
HPBP protein was added in the primary antibody incubation step. In
each panel, the same brain area (cingulate cortex area) was
photographed with the same magnification (see scale bar on panel A).
doi:10.1371/journal.pone.0009099.g003
Figure 4. DING immunochemistry in the mouse brain. Different
brain areas were photographed on control mouse brain sections
labeled by anti-DING immunochemistry, using diaminobenzidine as
revelator dye. The different brain regions are: the cerebral cortex
(panels A and C), the sub-ventricular zone or SVZ (panel B), the
thalamus (panel D), the granular layer of the dentate gyrus (panel E)
and epithelial cells from blood vessels (panel F). Scale bars represent
20 mm for panel A or 40 mm for panels B to F. In panel A, black arrows
indicate brain cells with intense DING labeling throughout the whole
nucleus while black asterisks refer to brain cells with small patches of
DING labeling in poorly labeled nuclei.
doi:10.1371/journal.pone.0009099.g004
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In the skin, a massive DING protein-positive staining was
observed in the stratum corneum, epidermis (including basal
keratinocytes) and cutaneous underlying muscles (Figures 6A
and 6B). In the dermis, only fibroblasts were strongly labeled with
anti-DING antibody. However, a weak DING protein labeling
was found in the dermis extracellular matrix mainly consisting of
collagen fibers (Figures 6A and 6B).
In the heart, muscle fibers were mildly stained with anti-DING
antibody in their entirety, including cardiomyocyte nuclei. DING
protein was also detected in the nuclei of endothelial cells from
blood vessels (data not shown).
The presence of a heterogeneous DING protein labeling was
observed in the aortic media and adventitia. An intense labeling
was evidenced in the myocyte and fibrocyte nuclei while a slighter
labeling was displayed in the aortic amorphous ground substance
enriched in chondroitin sulfate. We observed a lack of DING
protein staining in elastic concentric membranes and collagen
fibrils of the aorta (data not shown).
In the lung, a positive DING protein labeling was identified in
cells of the pulmonary alveoli and bronchioles with folded mucous
membranes (Figures 6C and 6D). DING protein labeling is
mainly concentrated in cell nuclei. A positive staining is also
present in cytoplasm but in a more diffuse pattern.
In the liver, all the hepatocytes are stained with anti-DING
antibody. A strong staining was localized in the nucleus and
plasma membrane of hepatocytes while a weaker staining was
noticed in the cytoplasm (Figures 6E and 6F).
Altogether, these results clearly substantiate the presence of
DING protein in all tested mouse tissues. At the cellular level, the
strongest labeling was generally localized in nuclei and to a lesser
extent in the cytoplasm of considered cells. Moreover, it is
noteworthy that DING proteins were rarely spotted in the
extracellular matrix. Indeed, DING proteins were only found in
the aortic amorphous ground substance or in the skin epidermis.
Discussion
Origin of Mice DING Proteins
The origin of DING proteins is prone to controversy [11].
Indeed, in the post-genomic era, their genes are still consistently
missing from databases and the few partial nucleic sequences
identified in non-annoted parts of genomes are highly similar to
bacterial DING representatives, such as Pseudomonas DING
proteins. In addition, their codon usage is similar to that of
Pseudomonas, leading to the hypothesis of a bacterial origin [10].
Because of the numerous biological implications of DING proteins
in eukaryotes, the hypothesis of Pseudomonas contamination has
been discarded [11,33], but the hypothesis of an unknown
microbial symbiosis with eukaryotes remains a viable hypothesis
[11]. In order to investigate the possibility of microbial symbiotic
origin of DING proteins in eukaryotes, we analyzed wild-type and
germ-free mouse plasma samples using western blot assays. The
specificity of the used antibodies has been checked using
competition assays (Figure 3). In addition, the experiment was
performed using different kind of polyclonal antibodies, targeted
against HPBP (Figure 2), and targeted against the very conserved
N-terminal peptide of DING proteins (supporting document –
Figure S1). The similar patterns obtained in both experiments
Figure 5. Characterization of DING-labeling in brain cells. Anti-
DING/anti-NeuN double staining was performed in brain sections of
control mice to detect DING-expressing neurons (panel A: granular layer
of the dentate gyrus; panel B: cerebral cortex). Diaminobenzidine
(brown labeling) and SG vector dye (blue labeling) were used to view
DING and NeuN, respectively. Activated microglia (panel C) and
astroglia (panel D) expressing DING proteins were revealed in brain
sections of soman-poisoned mice with anti-DING/GSA lectin or anti-
DING/anti-GFAP double staining immunochemistry, respectively. Blue
staining was obtained with SG vector (labeling of DING proteins in
microglia and GFAP in astrocytes) while brown staining was achieved
using diaminobenzidine (labeling of DING proteins in astroglia and GSA
lectin in microglia).
doi:10.1371/journal.pone.0009099.g005 Figure 6. DING immunochemistry in different mouse tissues.
Skin (panels A and B), lung (panels C and D) and liver (panels E and F)
were collected from control mice and processed for hemalun-phloxin-
saffron staining (panels A, C and E) or anti-HPBP immunochemistry
(panels B, D and F). The same magnification was used for all the
photographs (see scale bar on panel A). Abbreviations are: SC =
stratum corneum; E = epidermis; D = dermis; F = fibroblast; CF =
collagen fibers and M = cutaneous underlying muscles.
doi:10.1371/journal.pone.0009099.g006
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DING protein profiles were compared in both wild-type and
germ-free C56BL/6 mouse plasma. The present study shows a
similar distribution of DING proteins in either wild-type or germ-
free C57BL/6 mouse plasma. This indicates that the presence of
DING proteins in eukaryotes is likely not to be related to microbial
symbiosis nor to contaminations. Therefore, regarding data
provided in this study, the more likely hypothesis concerning the
origin of eukaryotic DING proteins is a synthesis by eukaryotic
cells themselves.
In addition, the presence of mouse plasma DING protein is
consistent with the recent purification of a human DING
representative HPBP in the blood as published by Morales et al.
[16]. The existence of DING proteins in mammalian plasma
suggests therefore that these proteins are synthesized by eukaryotic
cells and are subsequently secreted in the circulating blood. To
date, the secretion route of DING proteins remains unidentified.
The sequence of DING protein genes or the full sequencing of
HMW-DING proteins is likely to shed light on the understanding
of mechanisms involved in the secretion of these proteins.
Omnipresence of DING Proteins in Mouse Tissues
As assessed by western blot analysis, DING proteins were
detected in all explored mouse tissues, namely: brain, skin, heart,
aorta, lung and liver. Our present results provide substantial
evidence that the omnipresence of DING proteins in various
mouse tissues is consistent with data previously published in other
mammalian models. Indeed, the 40 kDa cotinine receptor, a
member of the DING protein family, was purified from rat brains
and sequenced [34]. More recently, the 38 kDa apolipoprotein
HPBP has been isolated from human blood and its structure was
solved using X-ray crystallography [16,35]. HPBP being a
apolipoprotein [16], it could be produced by hepatocytes and
could be subsequently secreted in the circulating blood. Therefore,
it is not surprising to detect DING proteins in both the mouse liver
and plasma, in keeping with substantiated evidence from our
experiments.
As mentioned above, only the 41 kDa DING protein was
present in mouse liver, heart, brain, skin or lung. Further, the
quantity of this protein was more or less similar in all
investigated tissues. However, the distribution pattern of
HMW-DING proteins was different depending on the nature
of the related tissue. A total of four major HMW-DING at
140 kDa, 71 kDa (double bands), 62 kDa and 52 kDa were
revealed in tissues, and two others at 130 kDa and 100 kDa were
revealed in plasma samples. For example, the 52 kDa HMW-
DING was predominant in the skin while the quantities of 140
and 71 kDa HMW-DING were more important in the liver as
compared to the other tested mouse tissues. The diversity of
HMW-DING proteins possibly results in different physiological
involvements. The various forms of DING proteins detected in
these assays, different than the classical 41 kDa form, might
correspond to higher molecular weight DING protein precursors
and truncated or maturated DING proteins. Because of the high
sequence conservation within the DING protein family, these
bands might also correspond to uncharacterized mouse DING
proteins.
Intracellular Localization of Mouse DING Proteins
DING proteins are mainly localized in the nucleus of every cell
types present in all investigated mouse tissues. Generally, nuclear
stainings are very intense, except in the brain where neuronal
nuclei exhibit either strong or reduced labeling. However, as
regards other cerebral cells such as microglia or astroglia, all
nuclei are deeply stained with anti-DING antibody. Since we
investigated the cellular localization of DING proteins with
antibodies that recognizes various DING protein forms, the
observed signal could be derived from any of these forms. The
presence of DING proteins in cell nucleus is consistent with
biological activities identified for some of these proteins. For
example, bacterial PfluDING protein isolated from Pseudomonas
fluorescens is competent to stimulate the proliferation of cultured
human fibroblasts as assessed by
3H-thymidine incorporation
experiment [7]. Another DING protein, p27
SJ, suppresses
expression of HIV-1 genome [36]. This suppression of expression
is mediated by the physical and functional association of p27
SJ
with human C/EBPb transcription factor and viral Tat
transactivator. C/EBPb is a factor stimulating HIV-1 gene
transcription and regulating the expression of several genes
involved in mammalian cell proliferation or differentiation
[3,36,37]. Tat transactivator is a viral protein triggering the
transcription of HIV-1 viral genes. Moreover, p27SJ possess a
phosphatase activity inducing a dysregulation at S and G2/M
phases in cell cycles related to alteration of Erk1/2 phosphory-
lation state [38]. In addition, the X-DING-CD4
+ seems to
interact with transcription factors in the nucleus, and is believed
to be involved in the resistance to HIV infection of non-
progressive patients [22,39]. Since DING proteins are clearly
involved in cell cycle regulation and cell proliferation which are
complex processes within the nucleus, it may implies a nuclear
localization of these proteins for an optimal activity. Our present
investigation provides substantial evidence of the nuclear
localization of DING proteins.
The nuclear localization of DING proteins raises the issue of the
pathways for these proteins to the nucleus after synthesis in the
cytoplasm. The import of proteins into the nucleus is tightly
regulated and specific nuclear localization signals (NLS) are
required for the transport process [40,41]. Concerning DING
proteins, none of the available protein sequences indicate the
presence of such a NLS. However, despite being mostly isolated,
sequenced and characterized as 38–41 kDa proteins, DING
proteins exist also as higher molecular weight proteins [4]. Our
study provides evidence to that effect. Then, it could be assumed
that NLS might be present in HMW-DING proteins rather than
in mature DING proteins. The sequencing of these HMW-DING
proteins would be useful to address this issue. DING proteins are
also detected in the cytoplasm of liver, lung, skin and aortic cells.
Nevertheless, the quantity of DING proteins in cytoplasm is much
lower than the quantity revealed in nucleus. DING proteins are
completely absent in the cytoplasm of cerebral cells, including
neurons, microglia and astroglia. Moreover, the liver is the only
tested tissue of our study for which DING proteins was massively
localized in the plasma membrane, reinforcing the hypothesis of a
possible secretion of these proteins from liver cells to the
circulating blood, via a secretion of the DING protein through
cell plasma membrane. Since our study demonstrates that 52 kDa
and 71 kDa-DING proteins are both intracellular and secreted,
this could argue in favor of an unconventional route for DING
proteins secretion rather than a secretion pathway via N-terminal
secretion signal peptides.
Conclusion
Our study hereby, provides extensive data as regards
intracellular DING protein localization in several mouse tissues.
DING proteins seem to be ubiquitous in all tested tissues (i.e.
brain, skin, heart, aorta, liver and lung) and exists as different
isoforms, since we identified, in addition to the common 41 kDa-
DING protein, High Molecular Weight DING proteins in all
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dependant: such proteins exhibit an intracellular localization in
the brain while these proteins are detected either in the nucleus
or cytoplasm of other investigated tissues. As for liver, DING
proteins were also recovered in the plasma membrane, findings
back up therefore the hypothesis of a possible secretion of DING
proteins from liver to circulating blood, as evidenced by the
presence of DING proteins both in intracellular and in plasma.
Finally, the comparison of western blot profiles performed on
blood plasma purified from wild-type and germ-free mice further
evidenced the assumption that DING proteins are likely to be
produced by eukaryotic cells.
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